Summary
- Current Price
- As of today, ACRS price is $4.20, up +1.45% on
- Current Price All-Time High
- ACRS price is currently -87.60% below its historical high of $33.88 set on
- Market Cap
- ACRS current market cap is $455M, up +172.93% over the past 365 days
- PE Ratio
- ACRS PE ratio is unknown
- Revenue
- ACRS current annual revenue is $7.83M, down -58.19% year-over-year
- Next Earnings
- The next earnings release for ACRS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aclaris Therapeutics, Inc. |
| Ticker | NASDAQ: ACRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aclaristx.com |
| Employees | 61 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $4.20 | ||
| Price, 1D Change | +1.45% | |
| $455M | ||
| - | ||
| - | ||
| 0.48 | ||
| $8M | ||
| Revenue, 1Y Change | -58.19% | |
| -$0.53 | ||
| EPS, 1Y Change | +69.00% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.53 | ||
| EPS Estimate | N/A | -$0.59 |
| EPS Est. Change | N/A | -10.63% |
| $7.83M | ||
| Revenue Estimate | N/A | $4.52M |
| Revenue Est. Change | N/A | -42.21% |
| $4.20 | ||
| Price Target | - | $7.00 |
| Price Tgt. Change | - | +66.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.93 | -$1.71 | -83.72% | |
| -$0.49 | -$0.53 | -7.38% | |
| -$0.59 | N/A | -10.63% | |
| -$0.75 | N/A | -41.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $16.54M | $18.72M | +13.15% | |
| $7.99M | $7.83M | -2.07% | |
| $4.52M | N/A | -42.21% | |
| $4.72M | N/A | -39.66% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +172.73% | ||
| -48.08% | ||
| +172.93% | ||
| -16.30% | ||
| -58.19% | ||
| -73.70% | ||
| +69.00% | ||
| +60.25% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $4.20 | ||
| $2.50 | ||
| SMA 200 vs Price | -40.39% | |
| $3.51 | ||
| SMA 50 vs Price | -16.32% | |
| 0.48 | ||
| $0.27 | ||
| 66.32 | ||
| 91.97% | ||
| 99.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $7.83M | ||
| -$0.53 | ||
| $542.00K | ||
| 6.93% | ||
| -$74.08M | ||
| -943.97% | ||
| -$64.92M | ||
| -829.58% | ||
| -$73.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.36 | ||
| 3.36 | ||
| - | ||
| 2 | ||
| -4.65 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 58.15 | ||
| 4.41 | ||
| -5.00 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $103.08M | ||
| $151.36M | ||
| $160.46M | ||
| $96.32M | ||
| $57.38M | ||
| $28.65M | ||
| $2.12M | ||
| $551.00K | ||
| $13.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $72.75M | ||
| $74.62M | ||
| $7.28M | ||
| $21.97M | ||
| $454.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$47.11M | ||
| $48.37M | ||
| -$5.86M | ||
| $111.00K | ||
| -$47.22M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wedbush | ||
| HC Wainwright & Co. | → | |
| Scotiabank | → | |
| Cantor Fitzgerald | → | |
| Scotiabank |
Analyst sentiment
Institutional ownership
Screeners with ACRS
FAQ
What is the ticker symbol for Aclaris Therapeutics, Inc.?
The ticker symbol for Aclaris Therapeutics, Inc. is NASDAQ:ACRS
Does Aclaris Therapeutics, Inc. pay dividends?
No, Aclaris Therapeutics, Inc. does not pay dividends
What sector is Aclaris Therapeutics, Inc. in?
Aclaris Therapeutics, Inc. is in the Healthcare sector
What industry is Aclaris Therapeutics, Inc. in?
Aclaris Therapeutics, Inc. is in the Biotechnology industry
What country is Aclaris Therapeutics, Inc. based in?
Aclaris Therapeutics, Inc. is headquartered in United States
When did Aclaris Therapeutics, Inc. go public?
Aclaris Therapeutics, Inc. initial public offering (IPO) was on October 6, 2015
Is Aclaris Therapeutics, Inc. in the S&P 500?
No, Aclaris Therapeutics, Inc. is not included in the S&P 500 index
Is Aclaris Therapeutics, Inc. in the NASDAQ 100?
No, Aclaris Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Aclaris Therapeutics, Inc. in the Dow Jones?
No, Aclaris Therapeutics, Inc. is not included in the Dow Jones index
When was Aclaris Therapeutics, Inc. last earnings report?
Aclaris Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Aclaris Therapeutics, Inc. report earnings?
The next expected earnings date for Aclaris Therapeutics, Inc. is May 7, 2026
Data Sources & References
- ACRS Official Website www.aclaristx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1557746/000110465926020540/0001104659-26-020540-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1557746/000110465926020540/0001104659-26-020540-index.htm
- ACRS Profile on Yahoo Finance finance.yahoo.com/quote/ACRS
- ACRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/acrs